According to the Cuban leader, the center is equipped with leading-edge equipment, with a large capacity of production and an outstanding staff working on the development of new products to treat a group of diseases.
Among them, he said, kidney and bladder cancer, chronic hepatitis B and C, and meningitis, as well as heart attack and diabetic foot ulcers. He also pointed out the benefit of 55,000 Cuban patients with Heberprot-P treatment, already registered in 23 countries, including Argentina, Venezuela, Ecuador, Colombia, Turkey, Russia, Ukraine, and Vietnam.
